BackNAYA Biosciences Common Stock Overview

NAYA Biosciences Common Stock Total Assets

NAYA Biosciences Common Stock's total assets is $25B.

Get informed when a big investor buys or sells

+ Follow
Total Assets
$24.66B
↓ 22.33% YoYΔ $-7.09B vs prior year quarter

Peer average

Loading

NAYA Biosciences Common Stock Total Assets History

Loading

NAYA Biosciences Common Stock vs. peers: Total Assets Comparison

Loading

NAYA Biosciences Common Stock Total Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

NAYA Biosciences Common Stock (IVF) FAQ

As of the most recent data (March 2026), IVF shows a total assets of $25B. That compares with $32B in the prior-year period — down 22.3% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, IVF's total assets is now $25B (was $32B) — a 22.3% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether NAYA Biosciences Common Stock is outperforming or lagging.

Tracking IVF's total assets over time shows whether NAYA Biosciences Common Stock is scaling, shrinking, or reshaping that part of the business. The current reading is $25B That compares with $32B in the prior-year period — down 22.3% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total assets page, Stockcircle has NAYA Biosciences Common Stock's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total assets (currently $25B) with ownership activity and broader fundamentals.

NAYA Biosciences Common Stock's total assets is $25B; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.